BTC Health (BTC) 2021年年度报告「ASX」.pdf

1、ANNUAL REPORT ANNUAL REPORT YEAR ENDING 30 JUNE 2021 YEAR ENDING 30 JUNE 2021 B BTCTC HEAHEALTHLTH LILIMITMITE ED D ASX:BTCASX:BTC .au BTC HEALTH|ANNUAL REPORT PG 1 2 412 19 41 43 46 Chairmans Letter Directors Report Corporate Governance Statement Financial ReportDirectors DeclarationAuditors Indepe

2、ndence Declaration Independent Auditors Report Shareholder Information Corporate Directory 48 Auditor Report Information ContentsContents42 BTC HEALTH|ANNUAL REPORT PG 2 I am pleased to report that despite the broader disruptions to the economy,our investments in BTC Speciality Health Pty Ltd and Bi

3、oImpact Pty Ltd(collectively referred to as BTC)have continued to perform strongly.We have achieved a number of important milestones that are central to the Companys growth strategy.Our three-pillar investment strategy comprises organic growth,product diversification and transformative mergers and a

4、cquisitions,with a central focus on innovative medical technologies and speciality pharmaceuticals.Organic growth.Sales of medical devices and consumables grew 25%to$7.3m in the 2020/21 financialyear.After normalising for a significant period of elective surgery closure in 2019/20,we estimate the un

5、derlying business grew 16%per annum,which is in line with our expectation of delivering double-digit growth.Our sales team have been highly successful in prospecting,educating and onboarding clinicians to use BTC products over those marketed by our competitors.We remain confident our products are di

6、fferentiated,cost effective and deliver better patient outcomes.New business comprised an increase in new hospital accounts of 9%,coupled with the expansion of new surgeon uptake within existing accounts.I am encouraged by the feedback we consistently receive from clinicians that our products provid